Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
44 drugs in development
By Therapeutic Area
top 6
R&D Momentum
95/100
Pipeline Velocity
74/100
Trial Completion Rate
64/100
Pipeline Concentration
26/100
Pipeline Freshness
64/100
Strategic Signals
Activity
Last 14 days
Mechanisms Underlying Endometriosis and Migraine Comorbidity
Effect of a Dual Orexin Receptor Antagonist on CSF Alzheimer's Disease Biomarkers
Relationship Between Sex Hormones, Postoperative Pain and Opioid Use: the Role of Immune Factors
Migraine in Adolescents
A Phase I Trial of Palliative Spatially Fractionated (GRID) Radiotherapy Using Intensity Modulated Proton Therapy
Aging, Geriatric Syndromes and Clonal Hematopoiesis
Dominantly Inherited Alzheimer Network (DIAN)
Hormonal Effects of Puberty-Related Alterations on Pain in Adolescents With Migraine
Phase I Study of Radiation Dose Intensification With Accelerated Hypofractionated Intensity Modulated Radiation Therapy and Concurrent Carboplatin and Paclitaxel for Inoperable Esophageal Cancer
Racial and Socioeconomic Differences in Chronic Low Back Pain
Sleep Trial to Prevent Alzheimer's Disease
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)